tm
Seeing Is Believing
tm
Seeing Is Believing
MNPR is currently covered by 8 analysts with an average price target of $109.94. This is a potential upside of $28.28 (-2.17%) from yesterday's end of day stock price of $112.38.
Monopar Therapeutics's activity chart (see below) currently has 24 price targets and 46 ratings on display. The stock rating distribution of MNPR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 74.79% with an average time for these price targets to be met of 275.64 days.
Highest price target for MNPR is $133, Lowest price target is $93, average price target is $109.94.
Most recent stock forecast was given by JEET MUKHERJEE from BTIG on 12-Aug-2026. First documented stock forecast 24-Sep-2020.
Currently out of the existing stock ratings of MNPR, 21 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Sep-2025
$133
$15.44 (13.13%)
$117
29 days ago
(12-Aug-2026)
7/8 (87.5%)
$18.1 (15.75%)
119
Buy Since 23-Jun-2025
$100
$12.32 (14.05%)
$100
5 months 11 days ago
(30-Mar-2026)
4/7 (57.14%)
$46.71 (87.65%)
33
Buy Since 10-Jan-2025
$123
$35.32 (40.28%)
$142
9 months 27 days ago
(14-Nov-2025)
2/4 (50%)
$45 (57.69%)
142
Buy Since 10-Oct-2025
$130
$42.32 (48.27%)
$2
11 months ago
(10-Oct-2025)
0/4 (0%)
$42.18 (48.03%)
Buy Since 03-Sep-2025
$115
$27.32 (31.16%)
$77
11 months 8 days ago
(02-Oct-2025)
1/2 (50%)
$17.79 (18.30%)
22
What is MNPR (Monopar Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MNPR (Monopar Therapeutics)?
Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?
Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?
Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?
